Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1539292-59-5 | tert-butyl 3-(4-(3-hydroxyprop-1-ynyl)phenylcarbamoyl)propylcarbamate | AA019EDQ | MFCD31561134
2183440-72-2 | N-(Azido-PEG3)-NH-PEG3-acid HCl salt | AA019EH2 | MFCD31692222
56393-56-7 | N-(2,5-dimethoxyphenyl)-4-methylbenzenesulfonamide | AA019EKF | MFCD00686787
1451392-80-5 | tert-Butyl 4a,7-dihydro-1H-dicyclopenta[b,c]azete-4(3aH)-carboxylate | AA019ENJ | MFCD23704693
1067186-56-4 | 2-(1-(4-Chlorophenyl)cyclopropyl)-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid | AA019EQO | MFCD18782752
116-41-6 | N-(2-methoxy-5-methylphenyl)-4-methylbenzenesulfonamide | AA019ETH | MFCD05170076
1391733-05-3 | 1-(Tetrahydrofuran-3-yl)piperazine hydrochloride | AA019EWS | MFCD19441814
13589-02-1 | H-Pro-Phe-OH | AA019FP2 | MFCD00037869
947303-87-9 | (R)-4-((Diethylamino)methyl)-N-(2-methoxyphenethyl)-N-(pyrrolidin-3-yl)benzamide | AA019FVE | MFCD21603814
327092-97-7 | 4-chloro-3-[(2,5-dichlorophenyl)sulfamoyl]benzoic acid | AA019GGJ | MFCD02708233